Objects
Dunn, Catherine, Hong, Wei, Gibbs, Peter, Ackland, Stephen, Sjoquist, Katrin, Tebbutt, Niall C., Price, Timothy, Burge, Matthew. Elsevier; 2021. Personalizing First-Line Systemic Therapy in Metastatic Colorectal Cancer: Is There a Role for Initial Low-Intensity Therapy in 2021 and Beyond? A Perspective From Members of the Australasian Gastrointestinal Trials Group.
Khasraw, Mustafa, Lee, Adrian, McCowatt, Sally, Kerestes, Zoltan, Buyse, Marc E., Back, Michael, Kichenadasse, Ganessan, Ackland, Stephen, Wheeler, Helen. Springer; 2016. Cilengitide with metronomic temozolomide, procarbazine, and standard radiotherapy in patients with glioblastoma and unmethylated MGMT gene promoter in ExCentric, an open-label phase II trial.
Paul, Christine L., Verrills, Nicole M., Ackland, Stephen, Scott, Rodney, Goode, Susan, Thomas, Ann, Lukeman, Sarah, Nielsen, Sarah, Weidenhofer, Judith, Lynam, James, Fradgley, Elizabeth A., Martin, Jarad, Greer, Peter, Smith, Stephen, Griffin, Cassandra, Avery-Kiejda, Kelly A., Zdenkowski, Nick, Searles, Andrew, Ramanathan, Shanthi. BioMed Central Ltd; 2024. The impact of a regionally based translational cancer research collaborative in Australia using the FAIT methodology.